BC Cancer clinical trial shows radiation treatments reduced by more than 90%
A BC Cancer Victoria trial using stereotactic radiotherapy with AI is allowing some prostate cancer patients to receive far fewer radiation sessions, in some cases as few as two instead of the typical 20–40. The trial began in July, has enrolled about 15–20 patients so far, and aims to reach 100 participants and finish within two years.
